ICD-10-CM Billable Code

Z67.A

Duffy phenotype

Clinical Classification Guidelines

Medical Intelligence & Overview

Duffy phenotype refers to specific variations of the Duffy blood group system, which are characterized by the presence or absence of antigens on red blood cells. These antigens can influence susceptibility to certain infectious diseases and affect blood transfusions. The classification of Duffy phenotypes is part of the ICD-10 coding system under Z67.A, which helps healthcare providers document and understand this particular blood group variation.

Causes & Symptoms

Clinical Causes: Genetic inheritance: Duffy phenotype variations are inherited traits determined by specific genes. Mutations in the FY gene: Changes in this gene influence the presence or absence of Duffy blood group antigens. Population genetics: Different populations around the world have varying frequencies of Duffy phenotypes, largely due to evolutionary factors and disease exposure.

Key Symptoms: Typically, Duffy phenotype does not cause symptoms or health issues on its own. However, certain phenotypes can affect susceptibility to infections like malaria caused by Plasmodium vivax. Blood compatibility issues may arise during transfusions if the Duffy status is unknown or mismatched.

Diagnostic & Treatment

Diagnosis Path: The Duffy phenotype is identified through blood tests that analyze the presence or absence of Duffy antigens on red blood cells. These include serological testing and molecular methods such as PCR to determine specific gene variations. Medical professionals may recommend testing when blood transfusions are planned or when studying disease susceptibility linked to blood groups.

Treatment Protocols: Since the Duffy phenotype itself does not manifest as a health condition, no treatment is necessary solely for its presence. Management focuses on blood transfusion compatibility and addressing any associated health concerns. For individuals prone to certain infections due to their Duffy status, preventative strategies or treatments may be recommended by healthcare providers.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Z67.A a billable ICD-10 code?
Yes, Z67.A is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Z67.A?
Clinical documentation must specify the nature of Duffy phenotype and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

phenotype duffy